FANCM is Required for the PAX3::FOXO1-Driven Oncogenic Program in Rhabdomyosarcoma [ChIP-Seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 18 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE292876_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1241794 and SRA study SRP572994. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8867839 Rh4 Native Cells, H3K27Ac (ChIP), Rep1 Rh4 Native Cells, H3K27…
- GSM8867840 Rh4 Native Cells, H3K27Ac (WCE), Rep1 Rh4 Native Cells, H3K27…
- GSM8867841 Rh4 Native Cells, H3K27Ac (ChIP), Rep2 Rh4 Native Cells, H3K27…
- GSM8867842 Rh4 Native Cells, H3K27Ac (WCE), Rep2 Rh4 Native Cells, H3K27…
- GSM8867843 Rh4 Native Cells, H3K27Ac (ChIP), Rep3 Rh4 Native Cells, H3K27…
- GSM8867844 Rh4 Native Cells, H3K27Ac (WCE), Rep3 Rh4 Native Cells, H3K27…
- GSM8867845 Rh4 Native Cells, ishFANCM_SMC, pRPA32 (ChIP), Rep1 Rh4 Native Cells, ishFA…
- GSM8867846 Rh4 Native Cells, ishFANCM_SMC, pRPA32 (WCE), Rep1 Rh4 Native Cells, ishFA…
- GSM8867847 Rh4 Native Cells, ishFANCM_SMC, pRPA32 (ChIP), Rep2 Rh4 Native Cells, ishFA…
- GSM8867848 Rh4 Native Cells, ishFANCM_SMC, pRPA32 (WCE), Rep2 Rh4 Native Cells, ishFA…
- GSM8867849 Rh4 Native Cells, ishFANCM_SMC, pRPA32 (ChIP), Rep3 Rh4 Native Cells, ishFA…
- GSM8867850 Rh4 Native Cells, ishFANCM_SMC, pRPA32 (WCE), Rep3 Rh4 Native Cells, ishFA…
- GSM8867851 Rh4 Native Cells, ishFANCM, pRPA32 (ChIP), Rep1 Rh4 Native Cells, ishFA…
- GSM8867852 Rh4 Native Cells, ishFANCM, pRPA32 (WCE), Rep1 Rh4 Native Cells, ishFA…
- GSM8867853 Rh4 Native Cells, ishFANCM, pRPA32 (ChIP), Rep2 Rh4 Native Cells, ishFA…
- GSM8867854 Rh4 Native Cells, ishFANCM, pRPA32 (WCE), Rep2 Rh4 Native Cells, ishFA…
- GSM8867855 Rh4 Native Cells, ishFANCM, pRPA32 (ChIP), Rep3 Rh4 Native Cells, ishFA…
- GSM8867856 Rh4 Native Cells, ishFANCM, pRPA32 (WCE), Rep3 Rh4 Native Cells, ishFA…
- GSE292872 FANCM is Required for the PAX3::FOXO1-Driven Oncogenic Program in Rhabdomyosarcoma [RNA-Seq] 21 samples same disease briefing · shares fancm, pax3, rhabdomyosarcoma, foxo1-driven, oncogenic, required, program
- GSE279337 Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma 40 samples same disease briefing · shares pax3, rhabdomyosarcoma
- GSE286950 PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 16 samples same disease briefing · shares pax3, rhabdomyosarcoma
- GSE329566 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [ChIP-Seq] 8 samples same disease briefing · shares rhabdomyosarcoma, chip-seq
- GSE332748 PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells 6 samples same disease briefing · shares pax3, rhabdomyosarcoma
- GSE313525 TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma 6 samples same disease briefing · shares rhabdomyosarcoma, oncogenic
- GSE131309 Opposing genetic and immune mechanisms shape oncogenic programs in synovial sarcoma 4 samples same disease briefing · shares oncogenic, program
- GSE303151 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [CUT&RUN] 50 samples same disease briefing · shares rhabdomyosarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.